Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab

British Journal of Ophthalmology

Volumn 96, Issue 1, 2012, Pages 21-23

  Eghøj, Maria Salling ^a   Sørensen, Torben Lykke ^a  

^a Mental Health Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ARTICLE; CENTRAL RETINAL THICKNESS; CONTROLLED STUDY; DRUG EFFICACY; EXUDATIVE MACULAR DEGENERATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TACHYPHYLAXIS; VISUAL ACUITY; VISUAL DISORDER; VISUAL SYSTEM PARAMETERS;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; TACHYPHYLAXIS; VISUAL ACUITY;

EID: 84455204035     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2011.203893     Document Type: Article

References (20)

1. Bressler NM, Bressler SB, Congdon NG, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 2003;121:1621-4. (Pubitemid 37392370)
2. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-51. (Pubitemid 39573742)
3. Klein R, Peto T, Bird A, et al. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004;137:486-95. (Pubitemid 38328641)
4. Kaiser PK, Brown DM, Zhang K, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 2007;144:850-7.
5. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci 1994;35:3974-9. (Pubitemid 24350660)
6. Spilsbury K, Garrett KL, Shen WY, et al. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularisation. Am J Pathol 2000;157:135-44. (Pubitemid 30641731)
7. Roh MI, Lim SJ, Ahn JM, et al. Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol 2010;248:635-40.
8. Shen WY, Yu MJ, Barry CJ, et al. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol 1998;82:1063-71. (Pubitemid 28451280)
9. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-83.
10. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31. (Pubitemid 44511557)
11. Schaal S, Kaplan H, Tezel TH. Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology 2008;115:2199-205.
12. Forooghian F, Cukras C, Meyerle CB, et al. Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina 2009;29:723-31.
13. Keane PA, Liakopoulos S, Ongchin SC, et al. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49:3115-20.
14. Hoffman BB, Taylor P. Neurotransmission: the autonomic and somatic motor nervous system. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th edn. New York: McGraw-Hill, 2001:115-54.
15. Forooghian F, Chew EY, Meyerle CB, et al. Investigation of the role of neutralizing antibodies against bevacizumab as mediators of tachyphylaxis. Acta Ophthal 2009;7:1-2.
16. Bakri SJ, Snyder MR, Reid JM, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 2007;114:855-9. (Pubitemid 46635858)
17. Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis 2002;8:119-26. (Pubitemid 36153599)
18. Tartar O, Yoeruek E, Szurman P, et al. Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization. Arch Ophthalmol 2008;126:782-90. (Pubitemid 351831327)
19. Frank RN. Growth factors in age-related macular degeneration: Pathogenic and therapeutic implications. Ophthalmic Res 1997;31:243-4.
20. 2-Agonists and exercise-induced asthma. Clin Rev Allergy Immunol 2006;31:163-80.